Hang Chen

Title: The Innovative Contributions of Hang Chen

Introduction

Hang Chen is a prominent inventor based in Boulder, Colorado. She has made significant contributions to the field of biopharmaceuticals, holding a total of 7 patents. Her work focuses on semaphorin receptors and their applications in diagnosis and therapy.

Latest Patents

One of her latest patents involves semaphorin receptors, which provides methods and compositions related to two classes of semaphorin receptors, SR1 and SR2. The invention details how these polypeptides can be produced recombinantly from transformed host cells using the disclosed SR encoding nucleic acids or purified from human cells. Additionally, the invention includes isolated SR hybridization probes and primers that can specifically hybridize with the disclosed SR genes. It also covers SR-specific binding agents, such as specific antibodies, and methods for making and using these compositions in the biopharmaceutical industry. Another notable patent is related to the systematic evolution of ligands by exponential enrichment, known as tissue SELEX.

Career Highlights

Throughout her career, Hang Chen has worked with various organizations, including Nexstar Pharmaceuticals, Inc. and the University of California. Her innovative research has significantly impacted the biopharmaceutical sector, particularly in the development of therapeutic agents.

Collaborations

Hang has collaborated with notable professionals in her field, including Kirk B. Jensen and Kevin N. Morris. These collaborations have further enhanced her research and contributions to the industry.

Conclusion

Hang Chen's innovative work and patents in the field of semaphorin receptors demonstrate her commitment to advancing biopharmaceutical research. Her contributions continue to influence the development of new diagnostic and therapeutic methods.